课题基金 / 基金详情

The role of innate immunity in inflammatory bowel disease

The role of innate immunity in inflammatory bowel disease
先天免疫在炎症性肠病中的作用
批准号:
15390223
负责人:
KOHGO Yutaka
金额:
$9.15万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2003
资助国家:
日本
项目状态:
已结题
起止时间:
2003 至 2006

项目摘要

项目成果

KOHGO Yutaka的其他基金

相似基金

相关文献

中文摘要
翻译
本研究的目的是确定抗菌肽在正常和炎症肠道中的作用,并通过重组防御素调节先天免疫来探索炎症性肠病的潜在治疗选择。结果表明,1)健康志愿者、克罗恩病(CD)和溃疡性结肠炎患者小肠隐窝中表达的人防御素5 (HD-5) mRNA和蛋白;2)CD患者的防御素和toll样受体基因谱与健康志愿者不同;3)CD患者的HD-5杀菌活性较健康志愿者减弱。4)从CD患者体内提取的proHD-5的氨基酸序列中,部分CD患者的HD-5的二硫桥消失,提示在炎症性肠病中,HD-5的功能受到翻译后修饰的调节。5)重组HD-5对胰蛋白酶和蛋白酶稳定,4%葡聚糖硫酸钠处理后小鼠的存活率提高。综上所述,本研究提供了HD-5在正常和炎症肠道先天免疫中的重要作用,为炎症性肠病提供了一种针对先天免疫受损的新的治疗选择。
英文摘要
The aim of this study was to determine the role of antibacterial peptides in normal and inflamed intestine, and explore a potential therapeutic option for inflammatory bowel disease through the regulation of innate immunity by recombinant defensins.As results, this study demonstrated that, 1) human defensin 5 (HD-5) mRNA and protein expressed in small intestinal crypts of healthy volunteers and patients with Crohn's disease (CD) and ulcerative colitis, 2) gene profiles of defensins and toll-like receptors in the patients with CD was different from that in healthy volunteers, 3) bactericidal activity of HD-5 derived from the patients with CD was attenuated compared with that of healthy volunteers, 4) whereas the amino acid sequence of proHD-5 extracted from the patients with CD, disulphide bridges of the HD-5 of some CD patients were disappeared, suggesting that the function of HD-5 was regulated by a post-translational modification in inflammatory bowel disease and 5) recombinant HD-5, which was stable for trypsins and proteases, improved the survival rate of mice treated with 4% dextran sodium sulfate-treated.In summary, this study provided an important role of HD-5 in innate immunity of normal and inflamed inteastine, and proposed a novel therapeutic option for inflammatory bowel disease, targeting the impaired innate immunity.
期刊论文(58)
专著(0)
科研奖励(0)
会议论文
Upregulation of hepcidin by interleukin-1beta in human hepatoma cell lines.
在人肝癌细胞系中,白介素-1β 上调铁调素。
DOI: --
发表时间: 2005
期刊: Hepatol Res. 33
影响因子: --
作者: [Inamura J, et al.]
通讯作者: et al.
Combined use of dendritic cells enhances specific antileukemia immunity by leukemia cell-derived heat shock protein 70 in a mouse model with minimal residual leukemia cells.
在具有最少残留白血病细胞的小鼠模型中,联合使用树突状细胞可增强白血病细胞衍生的热休克蛋白 70 的特异性抗白血病免疫力。
DOI: --
发表时间: 2006
期刊: Int J Hematol. 84(5)
影响因子: --
作者: [Iuchi Y, Kohgo Y, et al.]
通讯作者: et al.
Expression of LL-37 by human gastric epithelial cells as a potential host defence Mechanism against Helicobacter pylori.
人胃上皮细胞表达 LL-37 作为对抗幽门螺杆菌的潜在宿主防御机制。
DOI: --
发表时间: 2003
期刊: Gastroenterology 125
影响因子: --
作者: [Hase K, Kohgo Y, et al.]
通讯作者: et al.
自然免疫, マクロファージ・抗原提示細胞腸粘膜上皮におけるPaneth細胞の自然免疫機能と病原体認識機構.
先天免疫、巨噬细胞/抗原呈递细胞肠粘膜上皮潘氏细胞的先天免疫功能和病原体识别机制。
DOI: --
发表时间: 2004
期刊: Annual Review免疫 2005巻
影响因子: --
作者: [綾部時芳, 高後裕, 他]
通讯作者: 他
共 38 条
    Cytoprotective effects of bioactive molecules derived from bacteria in the intestinal biofilm
    • 批准号:
      22390148
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.98万
    • 财政年份:
      2010
    • 负责人:
      KOHGO Yutaka
    • 依托单位:
    Development of a novel treatment for inflammatory bowel disease via the regulation of the bacteria recognition system and effective molecules derived from bacteria
    • 批准号:
      19390194
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $10.07万
    • 财政年份:
      2007
    • 负责人:
      KOHGO Yutaka
    • 依托单位:
    ISOLATION AND STRUCTURE ANALYSIS OF SOLUBLE TRANSFERIN RECEPTOR FOR INTERNATIONAL ASSAY SYSTEM
    • 批准号:
      11557071
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $3.97万
    • 财政年份:
      1999
    • 负责人:
      KOHGO Yutaka
    • 依托单位:
    INTRINSIC ANTIMICROBIAL POLYPEPTIDE IN INFLAMMATROY BOWEL DISEASE
    • 批准号:
      11694231
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $5.18万
    • 财政年份:
      1999
    • 负责人:
      KOHGO Yutaka
    • 依托单位:
    海外基金